...Maryland drug company couldn't decide at its board meeting Wednesday whether it wanted to locate operations in Augusta. Genvec Inc., a maker of cancer and heart disease drugs, last month asked city economic developers to line up $10 million in...

...difficult market forced two promising Maryland biotechnology companies to shelve plans to go public. Rockville-based GenVec Inc., which is developing gene therapy treatments for heart disease, canceled plans for a 2.5-million share offering...